Paper31190862
miR-106b promotes proliferation and invasion by targeting Capicua through MAPK signaling in renal carcinoma cancer.
Miao LJ and 6 others. Onco Targets Ther, 2019. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. miR-106b promotes proliferation and invasion by targeting Capicua through MAPK signaling in renal carcinoma cancer. Papers, record 31190862. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31190862
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- miR-106b promotes proliferation and invasion by targeting Capicua through MAPK signaling in renal carcinoma cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10652276 | Relief of gene repression by torso RTK signaling: role of capicua in Drosophila terminal and dorsoventral patterning. | Genes Dev | 2000 | https://conductscience.org/library/papers/10652276 | PubMed |
| 2 | 12393275 | CIC, a member of a novel subfamily of the HMG-box superfamily, is transiently expressed in developing granule neurons. | Brain Res Mol Brain Res | 2002 | https://conductscience.org/library/papers/12393275 | PubMed |
| 3 | 15746962 | The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. | Biochem Cell Biol | 2005 | https://conductscience.org/library/papers/15746962 | PubMed |
| 4 | 15851026 | Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. | Cell | 2005 | https://conductscience.org/library/papers/15851026 | PubMed |
| 5 | 16717057 | Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. | Hum Mol Genet | 2006 | https://conductscience.org/library/papers/16717057 | PubMed |
| 6 | 17190598 | ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. | Cell | 2006 | https://conductscience.org/library/papers/17190598 | PubMed |
| 7 | 17255944 | A MAPK docking site is critical for downregulation of Capicua by Torso and EGFR RTK signaling. | EMBO J | 2007 | https://conductscience.org/library/papers/17255944 | PubMed |
| 8 | 17538086 | Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17538086 | PubMed |
| 9 | 18313224 | Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. | Cancer Treat Rev | 2008 | https://conductscience.org/library/papers/18313224 | PubMed |
| 10 | 20709800 | Loss of inducible nitric oxide synthase expression in the mouse renal cell carcinoma cell line RENCA is mediated by microRNA miR-146a. | Am J Pathol | 2010 | https://conductscience.org/library/papers/20709800 | PubMed |
| 11 | 20811155 | Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer. | J Clin Invest | 2010 | https://conductscience.org/library/papers/20811155 | PubMed |
| 12 | 21544542 | MicroRNAs as biomarkers of disease onset. | Anal Bioanal Chem | 2011 | https://conductscience.org/library/papers/21544542 | PubMed |
| 13 | 23092349 | MicroRNA in the pathogenesis and prognosis of esophageal cancer. | Curr Pharm Des | 2013 | https://conductscience.org/library/papers/23092349 | PubMed |
| 14 | 23658823 | Disease-specific survival in de novo metastatic renal cell carcinoma in the cytokine and targeted therapy era. | PLoS One | 2013 | https://conductscience.org/library/papers/23658823 | PubMed |
| 15 | 23803041 | Effects of microRNA-106 on proliferation of gastric cancer cell through regulating p21 and E2F5. | Asian Pac J Cancer Prev | 2013 | https://conductscience.org/library/papers/23803041 | PubMed |
| 16 | 24075926 | Progress in microRNA delivery. | J Control Release | 2013 | https://conductscience.org/library/papers/24075926 | PubMed |
| 17 | 24175769 | MicroRNA-122 promotes proliferation, invasion and migration of renal cell carcinoma cells through the PI3K/Akt signaling pathway. | Asian Pac J Cancer Prev | 2013 | https://conductscience.org/library/papers/24175769 | PubMed |
| 18 | 25572155 | Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma. | Am J Pathol | 2015 | https://conductscience.org/library/papers/25572155 | PubMed |
| 19 | 25676538 | Higher Expression of miR-182 in Cytology Specimens of High-Grade Urothelial Cell Carcinoma: A Potential Diagnostic Marker. | Acta Cytol | 2015 | https://conductscience.org/library/papers/25676538 | PubMed |
| 20 | 25682771 | MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review). | Oncol Rep | 2015 | https://conductscience.org/library/papers/25682771 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41869342 | miRNA/mRNA analysis of increased TGF-β pathways drive epithelial-mesenchymal transition and regulatory T cell differentiation. | Front Immunol | 2026 | https://conductscience.org/library/papers/41869342 | PubMed |
| 41301871 | Toxicological Impacts and Mechanistic Insights of Bisphenol a on Clear Cell Renal Cell Carcinoma Progression: A Network Toxicology, Machine Learning and Molecular Docking Study. | Biomedicines | 2025 | https://conductscience.org/library/papers/41301871 | PubMed |
| 41181710 | Gastric metastasis of renal cell carcinoma: features, mechanisms, and insights from existing literature. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41181710 | PubMed |
| 41155295 | miR-106b-5p as a Central Regulator of Cancer Progression and Chemotherapy-Induced Cardiotoxicity: From Molecular Mechanisms to Clinical Translation. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41155295 | PubMed |
| 40943553 | The Role of MCM7 and Its Hosted miR-106b-25 Cluster in Renal Cancer Progression. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943553 | PubMed |
| 40667343 | miRNA/mRNA analysis of increased TGF-β pathways drive epithelial-mesenchymal transition and regulatory T cell differentiation. | bioRxiv | 2025 | https://conductscience.org/library/papers/40667343 | PubMed |
| 40537745 | The MAP kinase negative regulator DUSP2 (dual specificity phosphatase 2) is controlled by oncogenic microRNA cluster miR-17-92, miR-106a-363 and miR-106b-25. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40537745 | PubMed |
| 38520545 | Exosomes in renal cell carcinoma: challenges and opportunities. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38520545 | PubMed |
| 36358827 | CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36358827 | PubMed |
| 35938021 | A Four-MicroRNA Panel in Serum as a Potential Biomarker for Screening Renal Cell Carcinoma. | Front Genet | 2022 | https://conductscience.org/library/papers/35938021 | PubMed |
| 35625981 | Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35625981 | PubMed |
| 35593122 | MicroRNA-744-5p suppresses tumorigenesis and metastasis of osteosarcoma through the p38 mitogen-activated protein kinases pathway by targeting transforming growth factor-beta 1. | Bioengineered | 2022 | https://conductscience.org/library/papers/35593122 | PubMed |
| 35317779 | MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35317779 | PubMed |
| 34767243 | MiR-106b-5p Promotes Malignant Behaviors of Cervical Squamous Cell Carcinoma Cells by Targeting TIMP2. | Reprod Sci | 2022 | https://conductscience.org/library/papers/34767243 | PubMed |
| 34070923 | The miR-106b/NR2F2-AS1/PLEKHO2 Axis Regulates Migration and Invasion of Colorectal Cancer through the MAPK Pathway. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34070923 | PubMed |
| 33571679 | Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis. | Mol Ther | 2021 | https://conductscience.org/library/papers/33571679 | PubMed |
| 33093529 | Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma. | Sci Rep | 2020 | https://conductscience.org/library/papers/33093529 | PubMed |
| 32978089 | Capicua in Human Cancer. | Trends Cancer | 2021 | https://conductscience.org/library/papers/32978089 | PubMed |
Genes25
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31190862
GET https://conductscience.org/api/papers/v1/31190862/references?page=2